Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities

Bhatia Neal D.; Vlahovic Tracey C.; Green Lawrence G.; Martin Gina; Lin Tina

首页> 外文期刊>Journal of drugs in dermatology: JDD >Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities

【24h】

Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities

机译：Halobetasol 0.01％乳液治疗下肢中度至重度斑块牛皮癣

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Topical corticosteroids (TCS) are the mainstay of treatment. Long-term safety remains a concern, limiting use, and posttreatment flare is common. Recently data were reported on the use of halobetasol propionate (HP) 0.01 % lotion in moderate or severe localized plaque psoriasis, once-daily for 8 weeks. In addition, a 2-week label-restricted study reported comparable efficacy to HP 0.05% cream. Data evaluating efficacy in specific locations has not been reported and while psoriasis commonly affects lower extremities treatment can be more problematic and burden of disease heightened.

机译：背景：牛皮癣是一种慢性免疫介导的疾病，其临床表达中的巨大变化。局部皮质类固醇（TCS）是治疗的主要支柱。长期安全仍然是一个令人担忧，限制使用，并且后病理耀斑是常见的。最近报告了在中等或严重局部斑块牛皮癣中使用Halobetasol丙酸盐（HP）0.01％乳液的使用，每日一次持续8周。此外，2周的标签限制研究报告了HP 0.05％乳膏的相当疗效。尚未报告评估特定位置的疗效，虽然牛皮癣通常影响下肢治疗可能会更加有问题，并且疾病的负担增强。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2019年第10期|共8页
作者
Bhatia Neal D.; Vlahovic Tracey C.; Green Lawrence G.; Martin Gina; Lin Tina;
展开▼
作者单位

Therapeut Clin Res San Diego CA 92123 USA;

Temple Univ Sch Podiatr Med Philadelphia PA 19122 USA;

George Washington Univ Sch Med Dept Dermatol Washington DC USA;

Bausch Hlth Americas Inc Petaluma CA USA;

Ortho Dermatol Bridgewater NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities [J] . Bhatia Neal D., Vlahovic Tracey C., Green Lawrence G., Journal of drugs in dermatology: JDD . 2019,第10期

机译：Halobetasol 0.01％乳液治疗下肢中度至重度斑块牛皮癣
2. Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Lower Extremities [J] . Tyring Stephen, Kircik Leon H., Yamauchi Paul, Journal of drugs in dermatology: JDD . 2020,第4期

机译：Halobetasol丙酸酯0.01％/ Tazarotene 0.045％洗剂中度至严重的牛皮癣：汇集相3下肢分析
3. Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis [J] . Blauvelt Andrew, Green Lawrence J., Lebwohl Mark G., Journal of drugs in dermatology: JDD . 2019,第3期

机译：曾经每日固定组合Halobetasol（0.01％）和塔拉替烯（0.045％）洗剂治疗局部中度至重度斑块牛皮癣的疗效
4. Establishment of treatment parameters for ALA-PDT of plaque psoriasis [C] . Mark R. Stringer, Research School of Medicine/Univ. of Leeds, Leeds, Photochemotherapy: Photodynamic Therapy and Other Modalities II . 1996

机译：斑块状银屑病ALA-PDT治疗参数的建立
5. Is whole body vibration treatment more effective than traditional physical therapy treatment for increasing lower extremity muscle strength in a female toddler with developmental delays? [D] . Ching, Karen E. 2016

机译：在发育迟缓的女性幼儿中，全身振动治疗是否比传统的物理治疗更有效地增加下肢的肌肉力量？
6. Safety and Efficacy of a Halobetasol 0.01/Tazarotene 0.045 Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05 Cream [O] . Neal D. Bhatia, David M. Pariser, Leon Kircik, 2018

机译：0.01％/他扎罗汀0.045％他扎罗汀0.045％固定组合洗剂治疗中度至重度斑块状牛皮癣的安全性和有效性：与丙酸卤倍他索0.05％乳膏的比较
7. Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01/tazarotene 0.045 lotion for moderate-to-severe plaque psoriasis [O] . Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, 2021

机译：治疗效果的后处理效果丙酸丙酸酯0.01％/塔拉替烯0.045％乳液中度至重度斑块牛皮癣

Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities

摘要

著录项

相似文献

相关主题

期刊订阅